insights_auto
Zašto je MVIR pao 2,15%?
Istražite detaljnijechevron_right
MVIR:STO
Medivir AB
1,55 SEK
arrow_downward
−2,15%(−0,034) 1D
7. lis, 17:29:47 GMT+2 · SEK
search
Svi simboli
| Simbol | Cijena | Promjena | Postotna promjena |
|---|
insights_autoGeneriranje najvažnijih uvida za MVIR...
Otvori
1,56 SEK
Najviša
1,58 SEK
Najniža
1,53 SEK
Trž. kap.
967,92 mil.
Prosj. kol.
1,71 mil.
Količina
1,17 mil.
52-tjed. najviša
2,88 SEK
52-tjed. najniža
0,34 SEK
EPS
−0,37 SEK
Dionice u optjecaju
624,18 mil.
Broj djelatnika
6
Otvori
1,56 SEK
Najviša
1,58 SEK
Najniža
1,53 SEK
Trž. kap.
967,92 mil.
Prosj. kol.
1,71 mil.
Količina
1,17 mil.
52-tjed. najviša
2,88 SEK
52-tjed. najniža
0,34 SEK
EPS
−0,37 SEK
Dionice u optjecaju
624,18 mil.
Broj djelatnika
6
Vijesti
Iz web-izvora i od partnera za vijesti
Naslovi.net
·
prije 1 dan
Wall Street: Nasdaq na novom rekordu
Lider Media
·
prije 19 sati
Na Wall Streetu rekord S&P 500 indeksa
Simply Wall Street
·
prije 53 minute
How Trial Enrollment Completion At Pulse Biosciences (PLSE) Has Changed Its Investment Story
Blockhead
·
prije 1 sat
FDUSD Issuer First Digital to Go Public on Nasdaq in $250 Million SPAC Deal
Profil
Medivir is a Swedish biotech company. Medivir focuses its research focus on oncology and particularly on innovative pharmaceuticals that meet substantial unmet medical needs. The pharmaceutical development work is conducted both in-house and through partnerships, usually with global pharmaceutical companies.
Medivir has a leading expertise in the design of protease inhibitors and in the science of nucleotides and nucleosides.
Medivir is listed on the Nasdaq Stockholm Mid Cap List.
In February 2020, Medivir announced that the company has signed a licensing agreement for Xerclear with Chinese company Shijiazhuang Yuanmai Biotechnology Co Ltd. The agreement gives SYB the right to register, manufacture and market the product in China. Wikipedia
Medivir AB – informacije
Glavni izvršni direktorChristine Lind
Zaposlenici6
Osnovano1988
Sjedište-
Sektor-
Web-lokacijamedivir.com